» Articles » PMID: 30053054

Generation and Optimization of a Green Fluorescent Protein-Expressing Transcription and Replication-Competent Virus-Like Particle System for Ebola Virus

Overview
Journal J Infect Dis
Date 2018 Jul 28
PMID 30053054
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Work with infectious Ebola virus is restricted to biosafety level (BSL) 4 laboratories. To overcome this limitation, life cycle modeling systems, which recapitulate part or all of the virus life cycle under BSL-1 or -2 conditions, have been developed. The tetracistronic transcription and replication-competent virus-like particle (trVLP) system is currently the most advanced of these systems and is particularly useful for drug screening. However, previous versions have used luciferase reporters, limiting the types of screening assays that can be performed. Here we describe the generation and optimization of a green fluorescent protein-expressing tetracistronic trVLP system, enabling high-content imaging and flow cytometry approaches.Summary: Transcription and replication-competent virus-like particle (trVLP) systems are powerful tools to model the life cycle of highly pathogenic Ebola viruses. Here we describe the generation of a novel, GFP-based trVLP system that allows high content imaging and flow cytometry approaches.

Citing Articles

Spatial and functional arrangement of Ebola virus polymerase inside phase-separated viral factories.

Fang J, Castillon G, Phan S, McArdle S, Hariharan C, Adams A Nat Commun. 2023; 14(1):4159.

PMID: 37443171 PMC: 10345124. DOI: 10.1038/s41467-023-39821-7.


Development of an imaging system for visualization of Ebola virus glycoprotein throughout the viral lifecycle.

Furuyama W, Sakaguchi M, Yamada K, Nanbo A Front Microbiol. 2022; 13:1026644.

PMID: 36406413 PMC: 9669576. DOI: 10.3389/fmicb.2022.1026644.


Functional interactomes of the Ebola virus polymerase identified by proximity proteomics in the context of viral replication.

Fang J, Pietzsch C, Tsaprailis G, Crynen G, Cho K, Ting A Cell Rep. 2022; 38(12):110544.

PMID: 35320713 PMC: 10496643. DOI: 10.1016/j.celrep.2022.110544.


Ebola Virus Glycoprotein Domains Associated with Protective Efficacy.

Bhatia B, Furuyama W, Hoenen T, Feldmann H, Marzi A Vaccines (Basel). 2021; 9(6).

PMID: 34200548 PMC: 8229685. DOI: 10.3390/vaccines9060630.


Therapeutic strategies to target the Ebola virus life cycle.

Hoenen T, Groseth A, Feldmann H Nat Rev Microbiol. 2019; 17(10):593-606.

PMID: 31341272 DOI: 10.1038/s41579-019-0233-2.